Literature DB >> 15718542

Use of antibiotics in suspected haemolytic-uraemic syndrome.

Bob Phillips1, Kay Tyerman, Simon M Whiteley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15718542      PMCID： PMC549116          DOI： 10.1136/bmj.330.7488.409

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  The work on penicillin at Oxford.

Authors:  H W FLOREY; E P ABRAHAM
Journal:  J Hist Med Allied Sci       Date:  1951       Impact factor: 2.088

Review 2.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

3.  Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis.

Authors:  Nasia Safdar; Adnan Said; Ronald E Gangnon; Dennis G Maki
Journal:  JAMA       Date:  2002-08-28       Impact factor: 56.272
  3 in total
  4 in total

1.  Using antibiotics in suspected haemolytic-uraemic syndrome: antibiotics should not be used in Escherichia coli O157:H7 infection.

Authors:  Stephanie Dundas; W T Andrew Todd; Marguerite A Neill; Phillip I Tarr
Journal:  BMJ       Date:  2005-05-21

2.  Evaluation of BBL CHROMagar O157 versus sorbitol-MacConkey medium for routine detection of Escherichia coli O157 in a centralized regional clinical microbiology laboratory.

Authors:  D L Church; D Emshey; H Semeniuk; T Lloyd; J D Pitout
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

3.  Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea.

Authors:  H F Geerdes-Fenge; M Löbermann; M Nürnberg; C Fritzsche; S Koball; J Henschel; R Höhn; H C Schober; S Mitzner; A Podbielski; E C Reisinger
Journal:  Infection       Date:  2013-01-05       Impact factor: 3.553

4.  Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012.

Authors:  N Launders; L Byrne; C Jenkins; K Harker; A Charlett; G K Adak
Journal:  BMJ Open       Date:  2016-01-29       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.